"Pratia Bydgoszcz to doświadczony ośrodek badań klinicznych. Pratia powstała w trosce o pacjentów, którzy zmagają się z chorobami przewlekłymi i chcą uzyskać dostęp do nowoczesnych metod leczenia, które są w fazie badań klinicznych. Prowadzimy badania w ponad 20 obszarach terapeutycznych między innymi w dermatologi, diabetologi, gastroenterologi, ginekologi, laryngologi, immunologi, kardiologi, neurologi, nefrologi, onkologi, ortopedia pediatrii, pulmonologi, reumatologi, a także badania dotyczące szczepionek. Badania kliniczne proponowane naszym pacjentom uzyskały zgodę Ministerstwa Zdrowia oraz mają pozytywną opinię niezależnej Komisji Bioetycznej."

During the past decade, Centrum Medyczne Pratia Bydgoszcz conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Medyczne Pratia Bydgoszcz" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Shire" with 3 trials sponsored, "ALK-Abelló A/S" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "H. Lundbeck A/S" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Pratia Bydgoszcz" #1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Pratia Bydgoszcz" are "Ulcerative Colitis" (6 trials), "Allergy" (1 trials), "Chronic Cough" (1 trials), "Crohn's Disease" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Centrum Medyczne Pratia Bydgoszcz" in a lesser frequency.

Most popular intervention types in "Centrum Medyczne Pratia Bydgoszcz" are "Drug" (10 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Mirikizumab" (2 trials), "Ontamalimab" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials) and "20-valent pneumococcal conjugate vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Medyczne Pratia Bydgoszcz" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Medyczne Pratia Bydgoszcz". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centrum Medyczne Pratia Bydgoszcz, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Medyczne Pratia Bydgoszcz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".